White label ELPA - ClinicalTrials.eu

Study on the Use of Iron Oxide Nanoparticles in MRI to Detect Lymph Node Metastasis in Patients with Newly Diagnosed Rectal Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Metastases to lymph nodes
- Rectal cancer
Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Sparsentan
Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Recruiting

3 1 1
Investigated drugs:
- Metformin Hydrochloride
Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

Recruiting

4 1 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- Efgartigimod Alfa
+1
Study on Benralizumab for Patients with Severe Asthma

Recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Benralizumab
Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Sodium Iodide (131I)
Study on Ropivacaine Hydrochloride for Reducing Pain After Hip Surgery in Patients Undergoing Periacetabular Osteotomy

Recruiting

3 1 1
Investigated diseases:
- Osteotomy
- Procedural pain
Investigated drugs:
- Ropivacaine Hydrochloride
- Saline
Study on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye’s Posterior Segment

Recruiting

3 1 1 1
Investigated diseases:
- Chorioretinitis
Investigated drugs:
- Fluocinolone Acetonide
Study of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies